相关实验视频
Updated: Jul 19, 2025

07:37
Assessment and Communication for People with Disorders of Consciousness
Published on: August 1, 2017
9.1K
为痴呆症患者及其护理人员的欧洲项目
Advances in experimental medicine and biology
|August 15, 2023
概括
目前的痴呆症治疗方法是有症状的. 未来的研究需要对年轻参与者进行更大,更长的研究,以探索神经退行性疾病的预防策略.
科学领域:
- 神经科学和老年学
- 公共卫生和卫生服务研究研究
背景情况:
- 痴呆症和阿尔茨海默病 (AD) 缺乏治愈疗法;目前的干预措施是症状性的.
- 现有的建议强调了未来需要进行更大队列,更长时间和更年轻参与者的预防研究.
- 在过去的十年中,欧洲的重要合作集中在支持神经退行性疾病患者及其照顾者.
研究的目的:
- 审查和介绍十年来欧洲的研究项目,专注于痴呆和神经退行性疾病.
- 突出了解疾病进展,患者支持,护理人员培训和早期检测方面的进展.
- 展示创新的方法,包括数字生物标志物,虚拟现实和痴呆症护理中的遗传咨询.
主要方法:
- 对多个欧洲研究项目的审查,包括前性队列研究 (ICTUS,RECAGE,AddNeuroMed).
- 分析了专注于轻度认知障碍 (MCI) 和阿尔茨海默病 (AD) 查和标准 (DESCRIPA) 的项目.
- 包括利用技术 (VRADA,RADAR) 和教育框架 (GECONEU,Erasmus+项目) 支持患者和护理人员的项目.
主要成果:
- 项目提供了对抗痴呆症药物不持续性和停药预测因素 (ICTUS) 的见解.
- 研究已有助于对预发性阿尔茨海默病的查指南 (DESCRIPA) 和了解疾病进展 (AddNeuroMed).
- 开发数字生物标志物用于早期AD检测和验证功能衰退的技术支持措施 (RADAR).
结论:
- 十年来,欧洲的合作研究促进了对痴呆症和神经退行性疾病的理解和支持.
- 创新的干预措施,包括认知和身体炼,数字生物标志物和护理人员培训,显示出希望.
- 专注于预防,早期检测和全面的患者/护理人员支持的持续研究至关重要.
关键词:
这是AD游戏.在 ASPADAD ASPAD 里面.添加神经医学 添加神经医学桥梁的桥梁是一个桥梁.描述 描述 描述没有签名的签名痴呆的权利 痴呆的权利E.L.S.O.M.C.I.I.I.E 的意思就是说欧洲项目 欧洲项目格科尼欧 (GECONEU) 是一个欧盟国家.游戏4 协同技能 技能这就是ICTUS ICTUS.在InfoCare上提供信息.在法学士 (LLM) 课程中.这就是PIAIA的意义.雷达 (RADAR) 是一种雷达.收购回收 收购回收 收购回收 收购回收这就是S.IN.CA.L.A.L.A的意义.故事2记住记住在这里,VRADAADA VRADAADA.通过iCONNECT,我们可以连接.相关概念视频
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
Peripheral Artery Disease III: Interprofessional Care
11
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Patient-centered Care
2.1K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.1K
Parkinson's Disease: Treatment
299
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
299

